Today: 29 April 2026
Mineral Resources shares slip after flirting with a 52-week high as China flags battery overcapacity
8 January 2026
1 min read

Mineral Resources shares slip after flirting with a 52-week high as China flags battery overcapacity

SYDNEY, Jan 8, 2026, 17:19 AEDT — Market closed

  • Mineral Resources (ASX:MIN) closed down 1.34% at A$56.49 after swinging between A$55.95 and A$58.63
  • Lithium peers were mixed: Pilbara Minerals fell 0.62% while Liontown rose 0.99%
  • Investors’ next focus is MinRes’ December-quarter report and briefing on Jan. 29, followed by half-year results on Feb. 20

Mineral Resources Ltd shares ended lower on Thursday after pushing to within a whisker of a 52-week high, a reminder that the rally in Australian lithium names is still a jittery one. The stock closed down 1.34% at A$56.49.

The move matters now because MinRes has become a quick read-through on sentiment around battery materials, even as it also sells iron ore. When the lithium tape softens, the stock can turn fast, and Thursday’s fade came after a sharp early-week jump.

Traders have also been weighing fresh signals out of China, the key market in the battery supply chain. China’s industry ministry warned on Thursday of overcapacity risks in the electric-vehicle and energy-storage battery sectors, urging manufacturers to rein in what it called “blind” capacity build-outs. Reuters

Peer moves were uneven. Pilbara Minerals closed down 0.62% while Liontown ended up 0.99%, underlining how stock-specific positioning is driving parts of the lithium complex.

MinRes traded in a wide band, hitting A$58.63 at the high and A$55.95 at the low, before slipping into the close. That puts the A$58.64 52-week peak back in view as a near-term ceiling, with the day’s low now the first level some short-term traders point to.

The next hard catalyst is close. The company’s calendar flags its December-quarter report and investor briefing on Jan. 29, with half-year financial results due on Feb. 20. Investors will be watching shipments and costs across its iron ore and lithium operations, and any update on pricing and volumes for spodumene — the hard-rock ore used to make lithium chemicals.

But the risk case has not gone away. If China’s push to curb battery industry overbuild feeds through into weaker pricing power across the chain, the sector’s rebound could stall, and the higher-beta names tend to wear it first.

Stock Market Today

  • Element Solutions Beats Q1 Earnings and Revenue Estimates on Strong Electronics Demand
    April 29, 2026, 10:01 AM EDT. Element Solutions Inc. (ESI) reported first-quarter 2026 earnings of 41 cents per share, excluding one-time items, beating the Zacks Consensus Estimate of 38 cents. Net sales rose 41% year over year to $840 million, surpassing the consensus of $744.4 million, driven by strong demand in its Electronics segment for AI infrastructure and high-performance electronics. The Electronics segment's organic net sales grew 15%, with adjusted EBITDA up 34%. However, net income fell 43% year on year to $56 million due to prior-year gains. ESI's cash decreased substantially, and debt rose to $2.06 billion. The company raised its full-year adjusted EBITDA outlook to $665 million-$685 million. Shares have surged 91.7% over the past year, outperforming the industry rise of 9.8%, while maintaining a Zacks Rank #3 (Hold).

Latest article

Lemonade Stock Jumps as Q1 Revenue Surge Sharpens Its 2026 Profit Test

Lemonade Stock Jumps as Q1 Revenue Surge Sharpens Its 2026 Profit Test

29 April 2026
Lemonade Inc reported first-quarter revenue of $258 million, up 71% from a year earlier, and narrowed its net loss to $35.8 million, or 47 cents a share. Shares rose 5.6% in premarket trading after results beat estimates. In-force premium climbed 32% to $1.33 billion, with customers up 23% to 3.14 million. The company raised its 2026 outlook and now expects full-year revenue of up to $1.203 billion.
Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

29 April 2026
Biogen lowered its 2026 adjusted earnings forecast to $14.25–$15.25 per share, citing research and development charges from recent acquisitions. First-quarter revenue rose 2% to $2.48 billion, with adjusted earnings of $3.57 per share, beating analyst estimates. Leqembi sales climbed 74% to $168 million globally.
Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Microsoft stock closes higher as Musk-OpenAI trial risk lands, with MSFT earnings in focus
Previous Story

Microsoft stock closes higher as Musk-OpenAI trial risk lands, with MSFT earnings in focus

DroneShield Limited stock slips as JPMorgan drops off the 5% holder list — what investors watch next
Next Story

DroneShield Limited stock slips as JPMorgan drops off the 5% holder list — what investors watch next

Go toTop